Submission Details
| 510(k) Number | K231653 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 06, 2023 |
| Decision Date | July 03, 2023 |
| Days to Decision | 27 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K231653 is an FDA 510(k) clearance for the BASHIR? .035 Endovascular Catheter, BASHIR? S-B .035 Endovascular Catheter, a Mechanical Thrombolysis Catheter (Class II — Special Controls, product code QEY), submitted by Thrombolex, Inc. (New Britain, US). The FDA issued a Cleared decision on July 3, 2023, 27 days after receiving the submission on June 6, 2023. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.5150.
| 510(k) Number | K231653 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 06, 2023 |
| Decision Date | July 03, 2023 |
| Days to Decision | 27 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | QEY — Mechanical Thrombolysis Catheter |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.5150 |
| Definition | To Mechanically Disrupt Thrombus And/or Debris In The Peripheral Vasculature. |